RA
The startup has developed a respiratory monitoring technology that provides continuous, real-time measurements of diaphragm function and respiratory muscle activity in critically ill patients. This precise data enables healthcare providers to enhance patient care quality while reducing associated treatment costs in intensive care settings.
Updated 3 months ago
Funding
$2.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a respiratory monitoring technology that provides continuous, real-time measurements of diaphragm function and respiratory muscle activity in critically ill patients. This precise data enables healthcare providers to enhance patient care quality while reducing associated treatment costs in intensive care settings.